Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028—study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation

INTRODUCTION: Despite antiretroviral therapy (ART), people living with HIV have higher rates of non-infectious chronic diseases. These conditions are driven by relatively high levels of inflammation persisting on ART compared with uninfected individuals. Chronic inflammation also contributes to HIV...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMJ Open
Glavni autori: Costiniuk, Cecilia T, Saneei, Zahra, Routy, Jean-Pierre, Margolese, Shari, Mandarino, Enrico, Singer, Joel, Lebouché, Bertrand, Cox, Joseph, Szabo, Jason, Brouillette, Marie-Josée, Klein, Marina B, Chomont, Nicolas, Jenabian, Mohammad-Ali
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2019
Teme:
HIV/AIDS
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6340429/
https://ncbi.nlm.nih.gov/pubmed/30659041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-024793
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items